Latest news
Here you can find news and updates by Pancreatic Cancer UK
Just 12% of pancreatic cancer patients given the chance to join a clinical trial
Only 12% of people with pancreatic cancer are given the chance to take part in a clinical trial, emphasising the lack of progress in developing treatments.
We’re demanding treatment breakthroughs. We’re demanding survival.
Today marks the launch of our Demand Survival Now petition, calling on governments across the UK to fund more research for treatment breakthroughs
Our response to the daraxonrasib clinical study and KRAS inhibitors
Our comment on daraxonrasib results and the promising group of therapies known as KRAS inhibitors.
Understanding KRAS Inhibitors: A new direction in pancreatic cancer treatment
A closer look at a promising group of treatments known as KRAS inhibitors these aim to treat cancers with a mutation in the KRAS gene.
Introducing The Big Picture
Help us build the biggest ever picture of pancreatic cancer care through our new pancreatic cancer registry.
Scottish and Welsh elections: What happens next?
The results of last week’s elections have reshaped politics across Scotland and Wales. In this blog, we look at what these changes mean for each nation and how they could impact people affected by pancreatic cancer.
Results from small pancreatic cancer vaccine trial show promise
Pancreatic Cancer UK's Head of Research, Dr Madina Kara comments on early trial results which found seven of the eight people whose immune system responded to a pancreatic cancer vaccine are still alive six years later.
An update on the PERT shortages
An update on our work to address the PERT shortages, including the progress we've made so far, the current supply situation, and what we still need to see to fully resolve the shortages.
Personal stories behind the breath test trial announcement
Announcing that the world’s first breath test for pancreatic cancer was entering a national clinical trial was one of the most significant milestones in our charity’s history. Its impact was amplified by supporters like Andrew sharing their story.
The Rare Cancers Act 2026 – the Bill has officially become law!
We are absolutely delighted that on Thursday 5th March, the Rare Cancers Bill passed its final stage in Parliament, receiving Royal Assent and becoming the Rare Cancers Act 2026.
What the National Cancer Plan means for people affected by pancreatic cancer
On the 4th February 2026 – World Cancer Day, the Secretary of State for Health and Social Care, Wes Streeting revealed the eagerly awaited National Cancer Plan for England.
New combination of drugs shown to effectively treat pancreatic cancer in mice
Our Head of Research, Dr Madina Kara, comments on the recent news that scientists from the Spanish National Research Centre have been able to eliminate pancreatic cancer tumours in mice using a combination of three different drugs.